Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew K L Goey

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Molecular Diagnosis & Therapy|February 3, 2022
The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer PatientsDoreen Z Mhandire, Andrew K L Goey
Cancer Biology & Therapy|July 22, 2014
Potential novel role of bevacizumab in glioblastoma and cervical cancerAndrew K L Goey, William D Figg
Pharmacological Research|January 17, 2016
UGT genotyping in belinostat dosingAndrew K L Goey, William D Figg
Therapeutic Drug Monitoring|February 2, 2023
Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human PlasmaSarah M Burke, Mustafa Kamal, Andrew K L Goey
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2023
Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasmaMelody F Myszkiewicz, Igor Puzanov, Andrew K L Goey
European Journal of Clinical Pharmacology|July 25, 2013
The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteersAndrew K L Goey, Irma Meijerman, Jos H Beijnen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[Dexrazoxane in anthracycline induced cardiotoxicity and extravasation]Andrew K L Goey, Jan H M Schellens, Jos H Beijnen, et al.
Leukemia Research|January 17, 2024
Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79bBen K Seon, Morihiro Okazaki, Jill Duzen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 8, 2024
Characterization of Nonclinical Drug Metabolism and Pharmacokinetic Properties of Phosphorodiamidate Morpholino Oligonucleotides, a Novel Drug Class for Duchenne Muscular DystrophyAndrew K L Goey, Marie Claire Mukashyaka, Yogesh Patel, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2014
Pharmacogenetics of membrane transporters: a review of current approachesTristan M Sissung, Andrew K L Goey, Ariel M Ley, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Molecular Diagnosis & Therapy|February 3, 2022
The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer PatientsDoreen Z Mhandire, Andrew K L Goey
Cancer Biology & Therapy|July 22, 2014
Potential novel role of bevacizumab in glioblastoma and cervical cancerAndrew K L Goey, William D Figg
Pharmacological Research|January 17, 2016
UGT genotyping in belinostat dosingAndrew K L Goey, William D Figg
Therapeutic Drug Monitoring|February 2, 2023
Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human PlasmaSarah M Burke, Mustafa Kamal, Andrew K L Goey
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2023
Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasmaMelody F Myszkiewicz, Igor Puzanov, Andrew K L Goey
European Journal of Clinical Pharmacology|July 25, 2013
The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteersAndrew K L Goey, Irma Meijerman, Jos H Beijnen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[Dexrazoxane in anthracycline induced cardiotoxicity and extravasation]Andrew K L Goey, Jan H M Schellens, Jos H Beijnen, et al.
Leukemia Research|January 17, 2024
Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79bBen K Seon, Morihiro Okazaki, Jill Duzen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 8, 2024
Characterization of Nonclinical Drug Metabolism and Pharmacokinetic Properties of Phosphorodiamidate Morpholino Oligonucleotides, a Novel Drug Class for Duchenne Muscular DystrophyAndrew K L Goey, Marie Claire Mukashyaka, Yogesh Patel, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2014
Pharmacogenetics of membrane transporters: a review of current approachesTristan M Sissung, Andrew K L Goey, Ariel M Ley, et al.
Pageof 3